胰腺癌中的寡转移（肝寡转移胰腺癌的同期切除术：在回顾性多中心分析中对安全胰腺手术时代的一项原则提出质疑）
Oligometastases in pancreatic cancer (Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis).
作者信息
Voss Nina, Izbicki Jakob R, Nentwich Michael F
机构信息
Department of General, Visceral and Thoracic Surgery University Medical Center Hamburg-Eppendorf Hamburg Germany.
出版信息
Ann Gastroenterol Surg. 2019 Apr 29;3(4):373-377. doi: 10.1002/ags3.12255. eCollection 2019 Jul.
Abstract
The aim of the present review was to analyze the current data on surgery of synchronous liver metastases in pancreatic ductal adenocarcinoma (PDAC) in curative intent. A review of the literature was carried out to identify the current international concepts regarding surgery of liver metastases of PDAC and, furthermore, we addressed the current challenges of resection of liver metastases of PDAC. Resection of liver metastases in PDAC may provide survival benefit without compromising safety and quality of life in a highly selected group of patients.
摘要
本综述的目的是分析目前关于胰腺导管腺癌（PDAC）同步肝转移癌根治性手术的现有数据。我们进行了文献综述，以确定目前关于PDAC肝转移癌手术的国际理念，此外，我们还探讨了PDAC肝转移癌切除目前面临的挑战。对高度选择的一组患者而言，PDAC肝转移癌切除术可能在不影响安全性和生活质量的情况下带来生存益处。
相似文献
1
Oligometastases in pancreatic cancer (Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis).胰腺癌中的寡转移（肝寡转移胰腺癌的同期切除术：在回顾性多中心分析中对安全胰腺手术时代的一项原则提出质疑）
Ann Gastroenterol Surg. 2019 Apr 29;3(4):373-377. doi: 10.1002/ags3.12255. eCollection 2019 Jul.
2
Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis.肝寡转移胰腺癌的同期切除术：在回顾性多中心分析中对安全胰腺手术时代一项原则的质疑
Surgery. 2016 Jul;160(1):136-144. doi: 10.1016/j.surg.2016.02.019. Epub 2016 Apr 3.
3
Patients with hepatic oligometastatic pancreatic body/tail ductal adenocarcinoma may benefit from synchronous resection.肝寡转移型胰体尾部导管腺癌患者可能从同步切除中获益。
HPB (Oxford). 2020 Jan;22(1):91-101. doi: 10.1016/j.hpb.2019.05.015. Epub 2019 Jun 29.
4
Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.伴有同步肝转移的胰腺导管腺癌的术前评估：不可切除性的诊断与评估
World J Gastroenterol. 2016 Dec 7;22(45):10024-10037. doi: 10.3748/wjg.v22.i45.10024.
5
Resection of isolated liver oligometastatic disease in pancreatic ductal adenocarcinoma: Is there a survival benefit? A systematic review.胰腺导管腺癌孤立性肝寡转移病灶切除术：是否存在生存获益？一项系统评价。
World J Gastrointest Surg. 2023 Jul 27;15(7):1512-1521. doi: 10.4240/wjgs.v15.i7.1512.
6
Feasibility of pancreaticoduodenectomy with synchronous liver metastasectomy for oligometastatic pancreatic ductal adenocarcinoma - A case-control study.胰十二指肠切除术同期肝转移瘤切除术治疗寡转移胰腺导管腺癌的可行性——一项病例对照研究
Ann Med Surg (Lond). 2020 Nov 13;62:490-494. doi: 10.1016/j.amsu.2020.11.037. eCollection 2021 Feb.
7
Oligometastatic Disease in Pancreatic Cancer - How to Proceed?胰腺癌寡转移疾病——如何应对？
Visc Med. 2017 Mar;33(1):36-41. doi: 10.1159/000455027. Epub 2017 Feb 10.
8
Metachronous hepatic resection for liver only pancreatic metastases.同期肝切除术治疗单纯性胰腺转移瘤。
Surg Oncol. 2020 Dec;35:169-173. doi: 10.1016/j.suronc.2020.08.005. Epub 2020 Aug 21.
9
Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality?肝寡转移胰腺癌的手术或局部区域治疗方法：神话、希望还是现实？
Cancers (Basel). 2019 Aug 1;11(8):1095. doi: 10.3390/cancers11081095.
10
Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1).胰腺癌伴肝脏寡转移患者经转化化疗后同期切除原发灶和肝转移灶与标准治疗的对比：一项多中心、前瞻性、随机对照 III 期临床试验（CSPAC-1）方案。
BMJ Open. 2019 Dec 8;9(12):e033452. doi: 10.1136/bmjopen-2019-033452.
引用本文的文献
1
Relationship between pancreatic cancer resection rate and survival at population level: systematic review.人群水平上胰腺癌切除率与生存率的关系：系统评价
BJS Open. 2025 Mar 4;9(2). doi: 10.1093/bjsopen/zraf007.
2
Surgical resection for pancreatic ductal adenocarcinoma with liver metastasis: is this the beginning of a new era?伴有肝转移的胰腺导管腺癌的手术切除：这是一个新时代的开端吗？
Hepatobiliary Surg Nutr. 2024 Dec 1;13(6):1054-1057. doi: 10.21037/hbsn-24-603. Epub 2024 Nov 21.
3
The Value of Primary Tumor Resection in Patients with Liver Metastases: A 10-Year Outcome.肝转移患者原发肿瘤切除的价值：10年随访结果
Ann Surg Oncol. 2025 Feb;32(2):1083-1092. doi: 10.1245/s10434-024-16386-3. Epub 2024 Nov 4.
4
Oligo-like liver metastasis: A novel prognostic indicator to improve survival in pancreatic cancer.寡聚样肝转移：一种改善胰腺癌生存率的新型预后指标。
Ann Gastroenterol Surg. 2023 Nov 13;8(3):481-489. doi: 10.1002/ags3.12753. eCollection 2024 May.
5
Currently Debated Topics on Surgical Treatment of Pancreatic Ductal Adenocarcinoma: A Narrative Review on Surgical Treatment of Borderline Resectable, Locally Advanced, and Synchronous or Metachronous Oligometastatic Tumor.当前关于胰腺导管腺癌外科治疗的争议话题：关于可切除边缘、局部进展期以及同时性或异时性寡转移瘤外科治疗的叙述性综述
J Clin Med. 2023 Oct 11;12(20):6461. doi: 10.3390/jcm12206461.
6
Prognostic Predicting Model of Pancreatic Body Tail Carcinoma Using Clinical and CT Radiomic Data.基于临床和 CT 影像组学数据的胰腺体尾部癌预后预测模型。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231186739. doi: 10.1177/15330338231186739.
7
Intraperitoneal Paclitaxel Treatment for Patients with Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination Provides a Survival Benefit.腹腔内注射紫杉醇治疗伴有腹膜播散的胰腺导管腺癌患者可带来生存获益。
Cancers (Basel). 2022 Mar 7;14(5):1354. doi: 10.3390/cancers14051354.
8
Survival Benefit of Resection Surgery for Pancreatic Ductal Adenocarcinoma with Liver Metastases: A Propensity Score-Matched SEER Database Analysis.胰腺导管腺癌伴肝转移行切除手术的生存获益：一项倾向评分匹配的监测、流行病学与结果（SEER）数据库分析
Cancers (Basel). 2021 Dec 23;14(1):57. doi: 10.3390/cancers14010057.
9
Individualized Prediction of Survival Benefits of Pancreatectomy Plus Chemotherapy in Patients With Simultaneous Metastatic Pancreatic Cancer.同步转移性胰腺癌患者胰十二指肠切除术联合化疗生存获益的个体化预测
Front Oncol. 2021 Sep 16;11:719253. doi: 10.3389/fonc.2021.719253. eCollection 2021.
10
New Potential Options for SBRT in Pancreatic Cancer.胰腺癌立体定向放疗的新潜在选择
Cancer Med J. 2021 Mar;4(Suppl 3):41-50. Epub 2021 Feb 18.
本文引用的文献
1
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.FOLFIRINOX 或吉西他滨作为胰腺癌的辅助治疗。
N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775.
2
Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases?伴有肝转移的胰腺癌、壶腹周围癌和胆管癌：在某些特定病例中我们是否应考虑手术切除？
World J Gastrointest Oncol. 2018 Aug 15;10(8):211-220. doi: 10.4251/wjgo.v10.i8.211.
3
[Oligometastasis in pancreatic cancer : Current state of knowledge and spectrum of local therapy].[胰腺癌寡转移：当前知识现状与局部治疗范围]
Chirurg. 2018 Jul;89(7):510-515. doi: 10.1007/s00104-018-0626-1.
4
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.《胰腺导管腺癌临床实践指南（2017 年第 2 版）》，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2017 Aug;15(8):1028-1061. doi: 10.6004/jnccn.2017.0131.
5
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?IV 期胰腺癌降期：一个新的适合手术的人群？
Ann Surg Oncol. 2017 Aug;24(8):2397-2403. doi: 10.1245/s10434-017-5885-4. Epub 2017 May 17.
6
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
7
Radical surgery of oligometastatic pancreatic cancer.寡转移胰腺癌的根治性手术
Eur J Surg Oncol. 2017 Feb;43(2):358-363. doi: 10.1016/j.ejso.2016.10.023. Epub 2016 Nov 9.
8
Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy?对于化疗有反应的伴有肝转移的胰腺癌患者，手术切除是否能发挥作用？
Eur J Surg Oncol. 2016 Oct;42(10):1533-9. doi: 10.1016/j.ejso.2016.06.398. Epub 2016 Jun 29.
9
Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis.肝寡转移胰腺癌的同期切除术：在回顾性多中心分析中对安全胰腺手术时代一项原则的质疑
Surgery. 2016 Jul;160(1):136-144. doi: 10.1016/j.surg.2016.02.019. Epub 2016 Apr 3.
10
Nationwide In-hospital Mortality Following Pancreatic Surgery in Germany is Higher than Anticipated.德国胰腺手术后的全国住院死亡率高于预期。
Ann Surg. 2016 Dec;264(6):1082-1090. doi: 10.1097/SLA.0000000000001693.
Zotero 插件